MS
CERE

Maven Securities’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Maven Securities’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-8,299
Closed -$114K – 1390
2021
Q1 		$114K Buy
+8,299
New +$121K 0.01% 988

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Maven Securities's CERE Position: Q2 2021 in Review

Maven Securities sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q2 2021, closing a stake of 8,299 shares — an estimated $114K sold.

Maven Securities first reported a position in CERE in Q1 2021 and held it in 1 quarter. The position peaked at $114K in Q1 2021. 82 funds tracked by Wall St. Rank hold CERE as of Q2 2021.

  • Maven Securities reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Maven Securities sold 8,299 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q2 2021, an estimated $114K.
  • Maven Securities first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • Maven Securities's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $114K in Q1 2021.
  • 82 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q2 2021.

Based on Maven Securities's 13F filing for Q2 2021, filed 16 Aug 2021.